Are you Dr. Lyons?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Dr. Timothy Lyons, MD is an endocrinologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina and Oklahoma.
Education & Training
Medical University of South CarolinaResidency, Internal Medicine, 1984 - 1986
Queen's University Belfast Faculty of MedicineClass of 1977
Certifications & Licensure
OK State Medical License 2002 - 2025
SC State Medical License 1991 - 2025
Clinical Trials
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Start of enrollment: 2016 Nov 03
Publications & Presentations
PubMed
- 609 citationsThe advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.Min-Xin Fu, Jesús R. Requena, Alicia J. Jenkins, Timothy J. Lyons, John W. Baynes
The Journal of Biological Chemistry. 1996-04-26 - 41 citationsRisk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis.Abdelrahim Alqudah, Michelle C. McKinley, Ross McNally, Una Graham, Chris J Watson
Diabetic Medicine. 2018-02-01 - 312 citationsEpidemiology of Traumatic Deaths: Comprehensive Population-Based AssessmentJulie A. Evans, Karlijn J P van Wessem, Debra McDougall, Kevin A. Lee, Timothy Lyons
World Journal of Surgery. 2010-01-01
Grant Support
- Early Markers Of Pre-Eclampsia In Native American With Type 2 DiabetesNational Center On Minority Health And Health Disparities2007–2011
- Lipoproteins And PEDF In The Vascular Complications Of DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Effects Of Chronic Green TEA Flavonoid Supplementation On Biomarkers Of OxidatiNational Center For Research Resources2007
- Markers And Mechanisms Of Vascular Disease In DiabetesNational Center For Research Resources2005–2007
- Apolipoprotein-Based Lipoprotein Subclass Profiles &Vasc Complic Of DiabetesNational Center For Research Resources2005–2007
- Markers &Mechanisms For Pre-Eclampsia In Women W/Type 1 DiabetesNational Center For Research Resources2004–2007
- Markers Amp;Mechanisms For Pre-Eclampsia In Women W/Type 1 DiabetesNational Center For Research Resources2006
- Apolipoprotein-Based Lipoprotein Subclass Profiles Amp;Vasc Complic Of DiabetesNational Center For Research Resources2006
- Apolipoproteins And The Complications Of Type 1 DiabetesNational Heart, Lung, And Blood Institute2004–2005
- Lipoproteins And Oxidative StressNational Heart, Lung, And Blood Institute2001–2005
- Epidemiology Of Diabetes Intervention &ComplicationsNational Center For Research Resources2001–2002
- Glycoxidation And Diabetic RetinopathyNational Center For Research Resources1997–2002
- Glycoxidation And Macrovascular Disease In DiabetesNational Heart, Lung, And Blood Institute1996–2000
- Glycoxidation And Macrovascular Disease In IDDMNational Center For Research Resources1998–1999
- Glycoxidation And Diabetic RetinopathyNational Eye Institute1994–1998
